EDITORIAL
Relevant cardiology studies marked the year 2015, with important changes in clinical practice. This review highlights some of these developments following the criterion of citations and impact on medical management.
One of the studies was on the optimal hemoglobin threshold for blood transfusion decision after cardiac surgery. Observational studies suggest that the use of red blood cell concentrate transfusions are associated with higher rates of mortality and complications, leading a constant pursuit of more restrictive protocols. The TITRe2 study was a randomized trial with 2003 patients undergoing elective cardiac surgery, in which hemoglobin reached levels lower than 9 g/dL and have been tested using two different strategies: (1) liberal transfusions of red blood cell concentrates or (2) a more restrictive strategy in which the threshold for transfusion was reduced to 7.5 g/dL 1 . The restrictive strategy was not better than the more liberal one regarding health costs or morbidity. Although it is a secondary outcome of the study, the fact that the more restrictive strategy was associated with higher mortality was worth of note, but it was not clear whether increased mortality was due to anemia. As pointed out in editorial comments, the study shows the need to develop institutional protocols to manage postoperative anemia 2 .
Another significant development refers to the . With regard to antibiotics therapy, aminoglycosides are no longer recommended in cases of endocarditis in native valves and, when used, must be in a single daily dose 5 .
The SPRINT study was one of the most important studies of the year and changes clinical practice by demonstrating that treating hypertensive patients to reduce the levels of systolic pressure to 120 mmHg offers additional benefit to the prevention of an adverse cardiovascular event in every 61 patients treated for 3.3 years. SPRINT researchers randomized 9361 patients older than 50, with high cardiovascular risk, systolic blood pressure between 130-180 mmHg for intensive care or conventional care of hypertension. There was a reduction in primary composite events (myocardial infarction, non-infarction coronary syndrome, stroke, heart failure or cardiovascular death) of 6.8% in the group of patients with conventional care to 5.2% in the group with intensive care (p<0.001). Mortality from all causes was also reduced from 4.5% to 3.3%. With the results of this study, medical practitioners can thoughtfully decide to reduce blood pressure that remains above 130 mmHg after treatment with antihypertensive drugs, as there is additional benefit in reduction to lower systolic pressure values 6 .
In addition to these important items, the manuscript of the International Journal of Cardiovascular Sciences with the greatest number of downloads in just one month was the study of Ana Colombo et al. 7 on the effect of chocolate intake on endothelial function in patients admitted with acute coronary syndrome. The authors conducted a randomized crossover study to demonstrate the vasodilator effect of chocolate on endothelial function, and this effect was superior to that of white chocolate intake.
